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Abstract  47 
Objectives:  48 
Urinary hormone concentrations are often adjusted to correct for hydration status. We 49 
aimed to determine whether first morning void urine hormones in growing 50 
adolescents require adjustments and, if so, whether urinary creatinine or specific 51 
gravity (SG) are better adjustments. 52 
 53 
Design and Methods:  54 
The study population was adolescents aged 10.1 to 14.3 years initially who provided 55 
fasting morning blood samples at 0 and 12 months (n=343) and first morning urine 56 
every three months (n=644). Unadjusted, creatinine and SG-adjusted hormonal 57 
concentrations were compared by Deming regression and Bland-Altman analysis and 58 
grouped according to self-rated Tanner stage or chronological age. F-ratios for self-59 
rated Tanner stages and age groups were used to compare unadjusted and adjusted 60 
hormonal changes in growing young adolescents. Correlations of paired serum and 61 
urinary hormonal concentration of unadjusted and creatinine and SG adjusted were 62 
also compared.  63 
 64 
Results:  65 
Fasting first morning void hormone concentrations correlated well and were unbiased 66 
between unadjusted or adjusted by either creatinine or SG. Urine creatinine 67 
concentration increases with Tanner stages, age and male gender whereas, urine SG 68 
was not influenced by Tanner stage, age or gender. Adjustment by creatinine or SG of 69 
urinary luteinizing hormone, estradiol, testosterone, dihydrotestosterone and 70 
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dehydroepiandrosterone concentrations did not improve correlation with paired serum 71 
concentrations.  72 
 73 
Conclusions: 74 
Urine steroid and LH concentrations in first morning void samples of adolescents are 75 
not significantly influenced by hydration status and may not require adjustments; 76 
however, if desired, both creatinine and SG adjustments are equally suitable.    77 
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Introduction 78 
Measurements of urinary gonadotropins and steroids in children and adolescents 79 
emerged as methods to estimate pubertal development and gonadal function early in 80 
the immunoassay era.
1-3
 Urine sampling provides an integrated measurement 81 
especially for hormones secreted in pulsatile manner such as luteinizing hormone 82 
(LH)
4
 or diurnally like sex steroids in early puberty, and is more acceptable to 83 
children and adolescents than venipuncture. The relatively high hormone 84 
concentrations in urine compared with blood or saliva, together with the ability to 85 
concentrate urine, is advantageous for assays with low sensitivity or analytes at low 86 
concentrations. However, an inherent problem of using urine is the wide and 87 
unregulated variation reflecting the individual’s fluid status.  88 
 89 
Urine dilution or concentration creates corresponding changes in urine solute 90 
concentrations so that adjustment of urine concentration may be required to avoid 91 
misinterpreting hormone excretion due to variation in hydration.
5
 Osmolality, specific 92 
gravity (SG) and creatinine measurements are used to adjust for hydration.
6
 Although 93 
measurement of osmolality by freezing point depression is considered the reference 94 
method
7
, it is laborious, time consuming and expensive so is usually replaced by SG 95 
and creatinine measurements particularly for large scale, field studies. Urinary SG is 96 
measured using a refractometer to compare light refraction of a urine sample against 97 
pure water standard or by reagent strips which measure the ionic strength of urine by 98 
color changes. Urine SG of sample is normalized to a population reference value. 99 
While SG measurement has been largely superseded by urine creatinine adjustment in 100 
clinical laboratories, SG adjustment for urine dilution remains standard in anti-doping 101 
laboratories and is used in some toxicology studies.
8
 Creatinine adjustment is based 102 
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on the assumption that (a) this end-product formed endogenously from muscle 103 
creatine is released into the bloodstream and excreted in urine at a constant rate 104 
depending only on total muscle mass
9
 and (b) endogenous hormones and creatinine 105 
undergo renal excretion at the same rate.
6
 Yet, CR excretion rate may be influenced 106 
by the growing muscle mass during puberty leading to potential systemic errors in 107 
using creatinine adjustments.
10
   108 
 109 
Some
11, 12
 but not other
13-17
 studies suggest creatinine or SG adjustment for 110 
measurement of urinary substances although such adjustments may be either 111 
unnecessary or even introduce additional measurement errors. Furthermore, none 112 
have focused on situations where creatinine is changing systematically due to somatic 113 
growth. Thus the present study aimed to determine whether the first morning void 114 
hormonal assessments carried out in growing young adolescents at various stages of 115 
pubertal progression require adjustments and, if so, to determine whether creatinine or 116 
SG adjustment was better.   117 
 118 
Materials and Methods 119 
 120 
Samples  121 
Adolescents aged 10.1 to 14.3 years initially were recruited from local secondary 122 
schools in the state of New South Wales (NSW), Australia. Ethical approval was 123 
obtained from the Human Research Ethics Committee, University of Sydney (HREC 124 
13094). Fasting morning blood samples were collected at 0 and 12 months (n=343) 125 
and first morning urine collected three monthly after 12 hr fasting at home by the 126 
adolescents between 7.00 am and 8.30 am (n=644). Post-menarcheal girls provided 127 
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samples in the mid-follicular phase (day 7-10) with the assumption of 28-32 day 128 
cycle. Serum and urine samples were stored at -80 C until analysis. The adolescents 129 
also provided a self-rating of puberty using line drawings based on the Tanner stages 130 
at 0 and 12 months.  131 
 132 
Assays 133 
Urine SG was measured by immersing a reagent strip (ChoiceLine 10, Roche 134 
Diagnostics) in freshly voided urine samples. Dipstick color changes were compared 135 
visually with the color chart to estimate the SG. Urine samples were subsequently 136 
stored at -80 C and subjected to three freeze-thaw cycles for luteinizing hormone 137 
(LH), creatinine and steroid analysis. The urine samples were first thawed and 138 
assayed for LH measurements with the Immulite 1000 LH (Siemens) as described 139 
previously.
18
 The within-assay coefficients of variation were <10%. The samples 140 
underwent second freeze-thaw cycle for the creatinine measurements. Urine 141 
creatinine concentrations were determined by the colorimetric alkaline-picrate (Jaffé) 142 
method (CREJ2, Roche Diagnostics, Cat. No. 04810716 190) on a Cobas C501 143 
analyzer (Roche Diagnostics GmbH, Indianapolis, IN). Calibrators (Roche 144 
Diagnostics, Cat. No. 10759350 190) were used for this automated system to generate 145 
a linear curve ranging between 375 and 55000 µmol/L and the limit of detection of 146 
375 µmol/L. The final urine thaw was for urine steroid measurement. Urinary and 147 
serum estradiol (E2), testosterone (T), dihydrotestosterone (DHT) and 148 
dehydroepiandrosterone (DHEA) were measured by liquid chromatography tandem 149 
mass spectrometry (LC-MS/MS) as modified from a previously described method for 150 
serum 
19
 and adapted for urine specimens following deconjugation, with details 151 
described in the Supplementary Materials.  152 
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 153 
The LH and steroid concentrations were adjusted to standard SG of 1.020 according 154 
to the formula [hormone concentrationsample X (1.020-1)/(SGsample-1)] 
20
 and to 155 
standard CR measurement of the present study adolescent population (12.40 mmol/L 156 
[n=644; F 331]) using the formula [hormone concentrationsample X 157 
(Creatininepopulation/Creatininesample)] where Creatininepopulation was defined as the mean 158 
of the urinary creatinine of the whole sample.  159 
  160 
Data Analysis 161 
The steroid and LH concentrations unadjusted and adjusted for SG or creatinine were 162 
compared by Deming (orthogonal) regression and deviance (Bland-Altman) analysis 163 
using MedCalc software. Based on using the same analyte with different adjustments, 164 
the variance ratio in the Deming regression was assumed to be unity. Non-165 
indepednence according to variations in the number of samples provided by each 166 
individual was ignored in this analysis. Descriptive statistics including mean, standard 167 
deviation (SD) and standard error of mean (SEM) were performed by SPSS version 168 
21. The F- ratios of age and Tanner stage group comparison for each hormone were 169 
calculated by one-way ANOVA separately for each gender.  170 
 171 
Results 172 
In first morning urine void samples (n=644), the mean (SD, range) creatinine 173 
concentration was 12.4 (4.5, 1.4 - 31.5) mmol/L with an overall gender difference 174 
being higher in males (P<0.05). The SG was 1.020 (0.0054, 1.005 - 1.030) without 175 
significant gender difference (P=0.054). Urine creatinine concentrations were 176 
progressively increased according to chronological age and to Tanner stage (Figure 1) 177 
9 
 
for both genders. Pooling genders, there were significant differences in urine 178 
creatinine concentrations by age and Tanner stage (P<0.05, two-way ANOVA) but 179 
not for urine SG according to age (P=0.29) or Tanner stages (P=0.22) (data not 180 
shown).  181 
 182 
Urinary LH, E2, T, DHT and DHEA concentrations, adjusted for either SG or 183 
creatinine, are compared according to Deming regression line and the deviance plots 184 
are shown in Figure 2. For each urinary hormone concentration, there was a good 185 
correlation between the SG and creatinine adjusted concentrations (R
2
: 0.69 - 0.85) 186 
free from proportional bias between adjustment methods.  187 
 188 
Similarly, Deming regression and Bland-Altman comparison between the unadjusted 189 
and adjusted hormone concentrations with either SG or creatinine (Table 1) also 190 
demonstrate lack of bias whether adjusted or not by either creatinine or SG.  191 
 192 
The mean, SD and F-ratios of the unadjusted, SG adjusted and creatinine adjusted 193 
hormones according to Tanner stages and age groups in females and males are shown 194 
in Supplemental data, Tables 3-4 and Supplemental data, Table 5-6, respectively. The 195 
results show consistent estimates and progression according to age and Tanner stage 196 
of unadjusted, SG adjusted and creatinine adjusted urine LH and steroid 197 
concentrations. The mean, SD and F-ratios of serum hormones according to Tanner 198 
stage and age groups are shown in Supplemental data, Table 7 and 8.  199 
 200 
The correlation coefficient of paired urinary and serum hormone concentrations is 201 
given in Table 2. The unadjusted and adjusted (creatinine and SG) urinary LH, E2, T, 202 
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DHT and DHEA concentration showed similar correlation against serum. The 203 
samples were also grouped into three creatinine and SG percentile ranges (up to 25th 204 
percentile, between 25th to 75th percentile and above 75th percentile) and regression 205 
analysis was performed between unadjusted/adjusted urine hormone concentrations 206 
against serum hormone concentrations (data not shown). There were no 207 
improvements in the correlation coefficient values within the groups. Dividing the 208 
same percentiles according to gender also did not improve the correlations between 209 
the urine unadjusted/adjusted hormones against serum hormones concentrations (data 210 
not shown). 211 
 212 
Discussion  213 
Urinary measurement of reproductive hormones is a convenient means to evaluate 214 
pubertal status and gonadal function for field population studies. In clinical settings, 215 
adjustment based on the assumption of stable urine creatinine excretion is commonly 216 
used to adjust for variations in hydration although other techniques such as regression 217 
normalization or log transformation are proposed.
10, 21
 As an end metabolite of muscle 218 
creatine, urine creatinine is determined by total muscle mass in addition to other 219 
factors such as age, gender, diet (meat consumption), physical activity, and body mass 220 
index some of which exert their effects via changes in muscle mass.
6, 17, 22, 23
 Hence 221 
one aim of the present study was to determine for the first time whether creatinine 222 
adjustment was valid or required for longitudinal studies of growing adolescents.  223 
 224 
Our findings confirm that the first morning urine creatinine concentration increases 225 
with age and Tanner stages and was higher among males. However, adjustment for 226 
urine creatinine was no better or worse than adjustment for SG or even no adjustment. 227 
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This may reflect the fact that we studied first morning void urine samples which 228 
control hydration, whereas similar interpretation may not apply to urine sampled at 229 
random when hydration state may vary more. Our findings are consistent with 230 
previous studies showing prominent intra- and inter-individual variability in 231 
creatinine excretion of second morning and 24h urine samples in adults due to 232 
variable fluid intake.
17
 Significantly higher creatinine levels in morning versus 233 
afternoon,
24
 in evening spot samples
6
 and creatinine loss due to multiple freeze-thaw 234 
cycles have also been reported
25, 26
 all of which introduce systematic errors in use of 235 
urine creatinine for dilution adjustments. Thus, although studies have suggested 236 
alternative adjustment based on SG in adult humans and primates,
27, 28
 none have 237 
focused on the need for SG adjustments in first morning voids of growing 238 
adolescents.   239 
 240 
SG is readily measured by reagent strip for field studies without needing a laboratory. 241 
Previous studies demonstrate good agreement between SG measurements by reagent 242 
strip versus refractometer
29, 30
 or osmolality.
30-32
 SG measurement by reagent strip is 243 
widely used in clinical applications.
32, 33
 Although refractometer urine SG may be 244 
influenced by disease states leading to high serum protein or glycosuria,
7, 34
  reagent 245 
strip SG is not affected by glucose, only minimally by urea and albumin, but may be 246 
affected by the rare instances of alkaline urine.
31
 Urine SG reading may also be 247 
influenced by diet, environment and the renal reabsorption capacity.
35
 Among 248 
adolescents, we find that urine SG measured with reagent strips is systematically not 249 
influenced by age or gender consistent with previous reports. 
22, 36
 250 
 251 
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Limits of acceptable creatinine and SG measurements vary between studies. 252 
Generally, urine is considered too dilute when the SG and creatinine levels are lower 253 
than 1.010 and 0.5 g/l (4.4 mmol/L), respectively, and too concentrated where SG and 254 
creatinine levels higher than 1.030 (or 1.035) and 3 g/l (26.5 mmol/L), respectively.
17, 255 
35
 However, due to the standardized method of collection and hydration (first morning 256 
void), the present study did not discard any samples as too dilute or too concentrated. 257 
  258 
The present study demonstrated that the fasting first morning void urine hormone 259 
concentrations adjusted by creatinine correlated well with those adjusted by SG in this 260 
adolescent population. This is consistent with previous reports that used randomly 261 
collected or timed urine collection from children and adults showing good 262 
correlations when creatinine and SG adjustments were compared directly
5, 12, 21, 23, 35, 263 
37
 or with adjustment according to both
5, 27, 28
 including a reduced variation using 264 
these adjustments in some studies. 
10, 12
 However, the present study shows that neither 265 
of the adjustment methods for first morning void urine sample of adolescents were 266 
significantly improved compared to unadjusted hormone concentrations. These 267 
observations are consistent with previous reports for creatinine adjustment of urine 268 
steroid measurements in adult women. 
38, 39
  269 
 270 
In studies where the urinary hormone concentrations were correlated with paired 271 
circulating serum concentrations, the urinary unadjusted concentration or 272 
concentration expressed by volume of urine correlates better than the adjustment 273 
based on analyte to creatinine ratios,
11, 13, 40
 although some studies have shown 274 
improved correlation with creatinine adjustments.
41, 42
 The present study demonstrated 275 
that the urinary hormone concentrations adjusted with creatinine and SG did not 276 
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improve the correlation with paired serum concentrations. These samples were also 277 
grouped into three creatinine and SG percentile ranges (25th, 25-75th and 75th) to 278 
replicate non-fasting conditions with wider variation in hydration status. However, no 279 
improvement was observed in terms of correlation between the unadjusted or adjusted 280 
urine hormone and paired serum concentrations. These findings further support that 281 
the adjustments may not be necessary for first morning void urine samples. 282 
 283 
In conclusion, the present study shows that adjustment of urinary steroid and LH 284 
concentration for hydration state may not be required for first morning void 285 
specimens of even growing adolescents. If adjustments are required, then either 286 
creatinine or SG are equally suitable and provide comparable results. Reagent strip 287 
SG measurements are simple and sufficiently reliable, economical and time-saving for 288 
large numbers of urine sampling in long-term field studies.  289 
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Tables 407 
Table 1: Comparison of unadjusted against SG and CR adjusted urinary hormone 408 
measurements. The slope, intercept and 95% confidence interval (CI) were 409 
determined by Deming regression. The mean and 95% CI (± 1.96 SD) were derived 410 
from the Bland-Altman plots.  411 
412 
The slope, intercept and 95% confidence interval were determined by Deming regression. The mean and 95% CI (±1.96 SD) 413 
were derived from the Bland–Altman plots. 414 
UA: unadjusted; SG: specific gravity adjusted; CR: creatinine adjusted; R2: correlation of determination; CI: confidence interval; 415 
E2: serum estradiol; T: testosterone; DHT: dihydrotestosterone; DHEA: dehydroepiandrosterone; LH: luteinizing hormone. For 416 
the Deming regression, the variance ratio was assumed to be unity. 417 
*All the P values were <0.0001.  418 
UA vs SG UA vs CR
Deming Regression Bland-Altman Deming Regression Bland-Altman
Slope 
(95% Cl)
Intercept
(95% CI)
r*
(95% CI)
Mean 95% CI
Slope
(95% CI)
Intercept
(95% CI)
r*
(95% CI)
Mean 95% CI
LH (IU/L)
0.94
(0.84 to 
1.03)
0.03
(-0.67 to 
0.73)
0.91 
(0.90 to 
0.92)
0.6
8.3,
-7.2
1.03 
(0.94 to 
1.11)
-0.39 
(-0.98 to 
0.19)
0.89 
(0.88 to 
0.91)
0.1
8.1, 
-7.8
E2 (ng/mL)
0.92 
(0.75 to 
1.09)
0.02 
(-0.19 to 
0.22)
0.92 
(0.91 to 
0.94)
0.1
2.0,
-1.8
1.08 
(0.93 to 
1.22)
-0.09
(-0.24 to 
0.07)
0.92 
(0.91 to 
0.93)
0.0
1.8, 
-1.8
T (ng/mL)
0.98 
(0.89 to 
1.06)
-0.17 
(-0.75 to 
0.42)
0.95 
(0.94 to 
0.96)
0.4
11.5,
-10.7
1.20 
(1.08 to 
1.31)
-1.23 
(-1.99 to 
–0.47)
0.94 
(0.93 to 
0.95)
-0.7
11.7, 
-13.2
DHT (ng/mL) 
1.12 
(0.74 to 
1.50)
-0.63
(-1.94 to 
0.68)
0.95 
(0.94 to 
0.95)
0.2
3.5,
-3.2
1.53
(0.71 to 
2.35)
-1.75 
(-4.44 to 
0.94)
0.90 
(0.89 to 
0.92)
-0.1
4.8, 
-5.0
DHEA (ng/mL)
0.90 
(0.81 to 
0.99)
0.65 
(-0.92 to 
2.22)
0.87 
(0.85 to 
0.89)
1.5
17.9, 
-14.9
1.07
(0.94 to 
1.20)
-1.58 
(-3.67 to 
0.50)
0.82 
(0.79 to
0.84)
0.2
17.6, 
-17.2
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Table 2: Pearson’s correlation coefficient and confidence intervals (in parentheses) of 419 
paired urinary and serum LH, E2,T, DHT and DHEA  (n=343). 420 
421 
UA: unadjusted; SG: specific gravity adjusted; CR: creatinine adjusted; E2: serum estradiol; T: testosterone; DHT: 422 
dihydrotestosterone; DHEA: dehydroepiandrosterone; LH: luteinizing hormone.  423 
Urine versus serum LH E2 T DHT DHEA
UA 
0.56 
(0.48 to 0.63)
0.73 
(0.67 to 0.77)
0.79 
(0.74 to 0.82)
0.44 
(0.35 to 0.52)
0.63 
(0.56 to 0.69)
SG 
0.57 
(0.50 to 0.64)
0.72 
(0.66 to 0.77)
0.79 
(0.74 to 0.83)
0.42 
(0.33 to 0.50)
0.60 
(0.52 to 0.66)
CR
0.56 
(0.48 to 0.63)
0.79
(0.74 to 0.82)
0.80 
(0.76 to 0.84)
0.35 
(0.25 to 0.44)
0.66 
(0.59 to 0.71)
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Figures 424 
 425 
Figure 1: Plot of urinary creatinine measurements of adolescents groups according to 426 
age (left panel) and Tanner stage (right panel). Data represents the creatinine mean 427 
and SEM. For the age plot, samples were from 3-monthly intervals (n=644) whereas 428 
for the Tanner stage plot, samples were from 0 and 12 months (n=359).  429 
22 
 
 430 
23 
 
Figure 2: Comparison of urinary LH, E2, T, DHT and DHEA concentrations adjusted 431 
by SG and creatinine. Comparison were made according to Deming regression 432 
analysis (left panels) and Bland-Altman plots (right panels). For the Deming plots, the 433 
slope is shown as a solid line and line of identity in fine dotted line. Insets are the 434 
regression formula and 95% confidence limits on the intercept and slope. The Bland-435 
Altman plots represent the differences between creatinine and SG adjusted hormone 436 
concentrations against the averages of the hormone concentrations adjusted with the 437 
two correction method. The solid line and the dashed lines represent the observed 438 
average and the 95% limit of confidence (± 1.96 SD), respectively. 439 
